You searched for:"Sérgio Pereira da Cunha"
We found (12) results for your search.Summary
Rev Bras Ginecol Obstet. 2002;24(2):107-112
DOI 10.1590/S0100-72032002000200006
Purpose: to analyze the effects of prenatal and perinatal complications and the neurological development of surviving twins when the other had died in utero. Methods: fourteen cases of twin pregnancies where one of the twins had died during the pregnancy were analyzed. These patients gave birth between 1988 and 1994 and were subsequently followed-up by the Department of Obstetrics, Pathology Division, at the Hospital das Clínicas, Faculty of Medicine of Ribeirão Preto, University of São Paulo. Data from prenatal and perinatal records as well as findings from the deceased twins' autopsies were analyzed. In 1996, requests were made for the children to have a neurological examination as part of the study. The examination included developmental assessment and pathological signs in the motor, sensory and sensitivy areas and superior cortical functions such as praxis and agnosia. Results: ten of the fourteen contacted subjects complied with the request for neurological examination. Of the ten examined children only one had abnormal neurological findings, presenting a light degree of spastic paresis of the left leg. The pregnancy evaluation showed five cases of monochorionic placenta and one case of monoamnionic pregnancy; six of the fourteen cases reached full-term. In six cases (42.8%) one of the fetus died during the second trimester and in the other they died during the third trimester. Only one newborn, who had Apgar 0 at the first minute, developed neurological sequelae. Conclusion: the neurological problem of one fetus may be a consequence of the perinatal complications that this fetus developed. The other newborns did not develop sequelae, possibly because of the conservatory management, trying to make the pregnancy reach 32 weeks or more, thus decreasing the complications of preterm delivery.
Summary
Rev Bras Ginecol Obstet. 2001;23(1):15-20
DOI 10.1590/S0100-72032001000100003
Purpose: to evaluate the seroprevalence of infection caused by HSV-2 among pregnant women delivering at the University Hospital, Faculty of Medicine of Ribeirão Preto (UHFMRP-USP) and to standardize laboratory techniques to be used for this purpose. Methods: a total of 1500 blood samples from pregnant women seen at the Obstetric Center of the Department of Gynecology and Obstetrics, UHFMRP-USP, between January 1st and October 31st, 1996, were evaluated. To determine the real prevalence of HSV-2 infection, the ELISA technique was standardized but, during its initial use, it was found to be not sufficiently specific to discriminate between the two viral types (75%). Thus, it became necessary to use a more specific technique and the method standardized for this purpose was Western blot, which can detect the specific HSV-2 viral protein. Results: the seroprevalence of herpes infection induced by the two viral types (HSV-1 and HSV-2) was 94.5% when ELISA was used. With the use of Western blot, a 32% seroprevalence of HSV-2 infection was detected in the studied population, whether symptomatic or asymptomatic. Conclusion: a high prevalence of carrier status for HSV-2 and HSV-1 infection was detected, as shown by the high rate of positivity for antibodies against this virus. ELISA did not show sufficient specificity to discriminate between HSV-2 and HSV-1 antibodies.
Summary
Rev Bras Ginecol Obstet. 1999;21(4):223-226
DOI 10.1590/S0100-72031999000400007
Purpose: to evaluate retrospectively the obstetrical and perinatal aspects of multiple pregnancies with the death of one fetus. Methods: a retrospective study on 26 pregnant women with multiple pregnancies and death of one twin. A conservative approach was followed and the patients were followed-up clinically with blood clotting tests. Results: in 50% of the cases fetal death occurred between 20 and 32 weeks of pregnancy. The time between death and resolution of pregnancy ranged from 6 to 148 h. Death of the other twin occurred in two cases. In 15 cases, the surviving twin had a good course, with two of them presenting slight neurological sequelae. In the other nine cases the other twin died after birth. No pregnant woman developed coagulation disorders.
Summary
Rev Bras Ginecol Obstet. 1999;21(5):251-258
DOI 10.1590/S0100-72031999000500002
Purpose: to evaluate whether prophylactic use of ampicillin could avoid or reduce maternal and perinatal infectious morbidity caused by premature rupture of membranes (PROM), and to extend the gestation period in those women. Methods: this was a prospective, randomized and double-blind study, carried out evaluating 121 pregnant women with PROM, randomized into two study groups. The treatment group (61 patients) received ampicillin and the control group (60 patients) received placebo. The placebo had the same characteristics as ampicillin (kind of packaging and color of the capsules) and was used in the same time regimen. The considered parameters for maternal infection were febrile morbidity (fever index), and the presence of chorioamnionitis and/or endometritis. The studied neonatal parameters were Apgar score (1st and 5th minutes), bacterial colonization of auditory canal, and blood culture. The statistical tests performed were Fisher's exact test, Wilcoxon, and chi². Results: it was observed that ampicillin did not prolong the gestation, nor did it reduce the postpartum febrile morbidity or the rates of chorioamnionitis and/or endometritis. Ampicillin did not reduce the perinatal infectious morbidity nor improve the birth outcomes. All these results were consistent in cases of less than 72 h PROM. The limited number of cases with time of PROM greater than 72 h did not permit statistical analysis free of type II error. Conclusions: based on these results it was possible to conclude that the prophylactic use of ampicillin by pregnant women with less than 72 h PROM did not reduce either infectious maternal or perinatal morbidity. However, the presence of group B Streptococcus agalactiae in the blood culture from a neonate in the control group showed the necessity to start antibiotic treatment of pregnant women colonized by this microorganism.
Summary
Rev Bras Ginecol Obstet. 2005;27(6):323-330
DOI 10.1590/S0100-72032005000600006
PURPOSE: to determine the validity of uterine artery Doppler velocimetry for the prediction of pregnancy complications in a population of low-risk nulliparae. SUBJECTS: a prospective study was conducted on 45 patients in their first pregnancy with no history of chronic diseases. Uterine artery Doppler velocimetry was performed between 24 and 26 weeks, with the determination of resistance index (RI), pulsatility index (PI), S/D ratio, and the presence or absence of incisure in the flow velocity wave. Data were analyzed by the Mann-Whitney test for non-parametric samples, and the Fisher exact test was used in the evaluation of the qualitative parameters. RESULTS: pregnancy complications were observed in twelve patients, with four cases of preeclampsia, one case of small for gestational age newborn (SGA NB), one case of SGA NB + preterm delivery (PTD), three cases of PTD, one case of fetal centralization, and two cases of presence of thick meconium in the amniotic fluid at the time of pregnancy resolution. We noted that RI (median 0.56 x 0.68), PI (median 0.98 x 1.29) and S/D ratio (median 2.2 x 2.9) were higher at the examination performed between 24 and 26 weeks in patients with complications and did not differ in preeclampsia and SGA cases. The presence of bilateral incisure showed 100 and 90% sensitivity, 60.2 and 62.5% specificity, 29.4 and 42,9% positive predictive value (PPV), and 100 and 95.2% negative predictive value (NPV) for the detection of preeclampsia or SGA and of any complication of pregnancy, respectively. An altered Doppler showed 83.3 and 83.3% sensitivity, 69.7 and 69.7% specificity, 33.3 and 50.0% PPV, and 95.8 and 92.0% NPV for the detection of preeclampsia or SGA and of any complication of pregnancy, respectively. CONCLUSION: high impedance indices and the presence of a bilateral incisure in the uterine arteries between 24 and 26 weeks of pregnancy seem to be good predictors of pregnancy and perinatal complications.
Summary
Rev Bras Ginecol Obstet. 2005;27(1):37-43
DOI 10.1590/S0100-72032005000100008
PURPOSE: to investigate the normal peak expiratory flow values in healthy pregnant women employing a portable expiratory apparatus (Mini-Wright Peak Flow Meter), and to relate the obtained measurements to each patient's height, body mass index (BMI) and age, along gestation. METHODS: a longitudinal prospective study including 26 pregnant women followed up from the first trimester to the 36th week of gestation and examined every four weeks. On the occasion of seven visits, the pregnant women performed forced exhaling into a portable expiratory apparatus three times, with the highest value being considered the peak expiratory flow. All measurements were made under the same investigator's supervision in order to reduce the margin of error. Pearson coefficient was used to calculate the correlation between flow and BMI, between flow and patient's height, and between flow and patient's age. RESULTS: the variation in flow values during pregnancy can be determined by flow = 328.32 -0.07 x week, with a Pearson coefficient equal to zero. To determine whether there was a difference in the correlation coefficients between BMI and flow, we compared the lowest coefficient (0.47 for week 30, flow = 123.49 + 7.64 x BMI) with the highest coefficient (0.59 for week 34, flow = 87.77 + 9.05 x BMI) of each studied time interval and obtained a value of 0.22, indicating a good correlation between the flow and BMI variables. There was a positive correlation between height and flow (Pearson = 0.61), with flow = -477.47 + 497.38 x height. The correlation coefficient between flow and age was 0.24, with the equation obtained in this case being non-linear. CONCLUSIONS: peak expiratory flow values did not change along gestation. Higher flows were observed in taller women. Pregnant women with a higher BMI before gestation presented higher flows. There was no correlation between flow and maternal age.
Summary
Rev Bras Ginecol Obstet. 1999;21(7):393-397
DOI 10.1590/S0100-72031999000700005
Purpose: to evaluate a possible relationship between fetal malformations (FM) and the use of sulfonylureas (SF) by diabetic pregnant women. Methods: we retrospectively studied 35 type 2 diabetic pregnant women followed at the Pathological Prenatal Care Outpatient Clinic of the University Hospital, Faculty of Medicine of Ribeirão Preto, from 1993 to 1995. Twenty-two of these women had been inadvertently using sulfonylureas during the 1st trimester of gestation (SF group). We determined their prevalence of FM and compared it to that observed for pregnant diabetic women who were only on diet or insulin therapy (group C). We also analyzed other variables such as time of disease, age, metabolic control, and prenatal care. Results: there was no significant difference between groups in terms of age range, duration of diabetes, glycemic control, or early start of prenatal care, with the prevalence of FM being similar for the two groups (8.3% in group C and 13.6% in group SF). The malformations observed in group SF were: renal agenesis, pulmonary hypoplasia and ribbon gonads (patient 1); short limbs and abnormally implanted toes (patient 2); cleft palate, low implanted ears, neck webbing and saddle nose (patient 3), and micrognathia, dysplastic ears, imperforate anus, hypospadia, polydactily, ventricular septal defect and atrial septal defect (patient 4) in group C. Conclusions: these data do not allow us to attribute the malformations detected in group SF to the use of sulfonylureas, although not usually described alterations in diabetic embryopathy occurred in this group.
Summary
Rev Bras Ginecol Obstet. 2007;29(1):41-47
DOI 10.1590/S0100-72032007000100007
PURPOSE: to verify the effectiveness of the maternal blood serum assays of the atrial natriuretic peptide (ANP) and nitric oxide (NO) to predict pregnancy complications. METHODS: the sample was made of 49 primigravidae women. They were included in the study at the 18th week of gestation, when blood sample was collected in order to analyze the serum assays. ANP was assayed by radioimmunoassay, using Euro-dianostica kits (2000), considering abnormal values over 237.4 pg/ml (95 percentil). NO level was evaluated by the chemiluminescence method, considering abnormal values over 17.8 mmol/l (percentil 95). For the statistical analysis of continuous quantitative variables with normal distribution, the unpaired t test was used; Mann-Whitney’s test was used for non parametrical quantitative samples; Fisher’s exact test, for the qualitative parameter assessment; and Pearson’s test for the assessment of correlations. RESULTS: there was no significant difference in the blood serum concentration of ANP between the group that presented complications during pregnancy and/or peridelivery (139.3±77.1 pg/ml) and the control group (119.6±47.0 pg/ml), nor in the serum concentration of NO, either, among the ones with complications in the pregnancy and/or in the peridelivery (11.1±4,6 mmol/l) and the control group (10.0±3.4 mmol/l). CONCLUSIONS: the results show that ANP and NO serum levels are not good predictors of pregnancy complications.